Newsroom
Sorted by: Latest
-
Vetoquinol: RÉSULTATS ANNUELS 2025
LURE, France--(BUSINESS WIRE)--Regulatory News: En commentant l’exercice 2025, Matthieu Frechin, Président-directeur général de Vetoquinol (Paris:VETO) a déclaré « Dans un contexte d’extrême volatilité, Vetoquinol confirme cette année encore la résilience de son modèle porté par une vision stratégique à long terme qui, combinée au pilotage réactif de nos dépenses, nous permet de délivrer un bon niveau de profitabilité. Nous poursuivrons activement cette stratégie en nous appuyant notamment sur...
-
Vetoquinol: 2025 Annual Results
LURE, France--(BUSINESS WIRE)--Regulatory News: Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, “In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level of profitability. We will actively pursue this strategy, relying in particular on...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS3191628794 Our Ref. MU4751 ISSUE NAME. Australia and New Zealand Banking Group Issue of EUR 750,000,000.00 Floating Rate Notes due September 2027 Series No 2174 Tranche 1 MTN INTEREST PERIOD. 30/03/2026 TO 29/06/2026 VALUE DATE. 29/06/2026 INTEREST RATE. 2.475 PCT NUM OF DAYS. 91 DAY BASIS. Actual/360 (A004) CURRENCY CODE. EUR INTEREST AMT PER DENOM. EUR 100,000.00 IS EUR 625.63 POOL FACTOR. N/A...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS2463121769 Our Ref. MO5346 ISSUE NAME. City Of Goteborg Issue of SEK 500,000,000.00 Green Floating rate Green notes due March 2028 Series no GB23 Tranche 1 MTN INTEREST PERIOD. 30/03/2026 TO 29/06/2026 VALUE DATE. 29/06/2026 INTEREST RATE. 3.189 PCT NUM OF DAYS. 91 DAY BASIS. Actual/360 (A004) CURRENCY CODE. SEK TOTAL INTEREST AMT. SEK 4,030,541.67 POOL FACTOR. N/A...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS2910541296 Our Ref. MR6869 ISSUE NAME. City of Stockholm Issue of SEK 1,650,000,000.00 Floating Rate Notes due September 2029 Series no 104 Tranche 1 MTN INTEREST PERIOD. 30/03/2026 TO 30/06/2026 VALUE DATE. 30/06/2026 INTEREST RATE. 2.429 PCT NUM OF DAYS. 92 DAY BASIS. Actual/360 (A004) CURRENCY CODE. SEK TOTAL INTEREST AMT. SEK 10,242,283.33 POOL FACTOR. N/A...
-
Omdia:顶级云厂商加码AI基础设施,2025年第四季度,全球云基础设施支出增长29%
伦敦--(BUSINESS WIRE)--(美国商业资讯)-- Omdia数据显示,2025年第四季度,全球云基础设施服务支出达到1109亿美元,同比增长29%。增速较上一季度进一步加快,这已是市场连续第六个季度实现超过20%的增长。随着企业对AI的需求从实验阶段转向生产部署阶段,顶级云厂商(hyperscalers)正持续加大投资,以扩展AI基础设施容量。展望2026年,Omdia预测全球云基础设施服务支出将增长27%。未来市场竞争的差异化将越来越取决于基础设施规模、资本效率以及AI智能体(AI agent)相关平台能力的完善程度上。 在本季度,亚马逊云科技(AWS) 的增长加速至24%,而微软Azure 和谷歌云分别实现39%和 50%的同比增长。AI 需求已不再局限于 GPU 等专用算力,同时也在推动CPU、存储和网络等更广泛的基础设施需求增长。企业正加速围绕agent、工作流和数据整合构建 AI 应用,对具备编排、扩展与治理能力的一体化云环境的需求持续增长。这进一步强化了云平台作为 AI 基础的核心地位,同时也推动更多传统及新兴工作负载向云端迁移。 与此同时,AWS、微软Azu...
-
GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported estimated full-year consolidated financial results for 2025,1 as reviewed by the Audit Committee and the Board of Directors on March 25, 2026. The Board of Directors will approve the final accounts on A...
-
GenSight Biologics publie ses résultats financiers consolidés estimés pour l’année 2025
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodégénératives de la rétine et du système nerveux central, publie aujourd’hui ses résultats financiers consolidés estimés pour l’année 2025, tels qu'ils ont été examinés par le Comité d'Audit et par le Conseil d'Administration en date du 25 mars 2026...
-
3D Investment Partners Discloses materials that organize in detail the process by which the Toho HD Audit and Supervisory Committee reached its decision not to start litigation, and that point out the unreasonableness of the decision-making process
TOKYO--(BUSINESS WIRE)--A fund which is provided discretionary investment management services by 3D Investment Partners Pte. Ltd. (together with such fund, “3D” or “we”) demanded, in December 2025, Toho Holdings Co., Ltd. (TOKYO: 8129, "Toho HD") file a lawsuit with respect to alleged breaches of the duty of care of the directors arising from past bid‑rigging misconduct involving current and former directors of Toho HD. In response, the Audit and Supervisory Committee of Toho HD decided not to...
-
Polish Investment and Trade Agency (PAIH) Names Ascend Elements’ Project Apex 2 Manufacturing Investment of the Year
WARSAW, Poland--(BUSINESS WIRE)--The Polish Investment and Trade Agency (PAIH) has named Ascend Elements’ Project Apex 2 its Manufacturing Investment of the Year, focused on the company’s development of the EU’s first fully integrated battery materials refining center that will turn spent lithium‑ion batteries into new, low‑carbon cathode materials using its Hydro‑to‑Cathode® technology. The Republic of Poland has granted Ascend Elements USD 320 million (approximately 1.22 billion PLN) to advan...